Gene and Cell Therapy
A section of Pharmaceutics (ISSN 1999-4923).
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Peptide-Based Vaccines: Current Progress and Future Challenges (Deadline: 20 June 2023)
- The Delivery of RNA-Based Therapeutics: New Strategies in Cancer and Gene Therapy (Deadline: 30 June 2023)
- Editorial Board Members’ Collection Series: Targeted Delivery of Anticancer Agents Engaging Cell Specific Mechanisms (Deadline: 30 June 2023)
- The Roles of Mesenchymal Stromal or Stem Cells in Cancer Therapy (Deadline: 30 June 2023)
- Gene Therapy for Neurological Disease (Deadline: 20 July 2023)
- Cancer Therapy Resistance: Choosing Kinase Inhibitors (Deadline: 20 July 2023)
- Non-viral Gene Delivery Systems, 2nd Edition (Deadline: 20 July 2023)
- State-of-Art in mRNA Therapeutics and Gene Delivery (Deadline: 20 July 2023)
- Cancer Vaccine Technologies: Current Progress and Future Perspectives (Deadline: 31 July 2023)
- Where Are We Now and Where Is Cell Therapy Headed? (Deadline: 31 July 2023)
- New Adjuvant Technologies for Next-Generation Vaccines (Deadline: 31 July 2023)
- Progress and Innovation on Nanosystems for Gene Therapy (Deadline: 20 August 2023)
- Nanocarriers: A Novel Strategy for Cell and Gene Delivery (Deadline: 20 August 2023)
- Pharmacogenomics: Recent Advances in Personalized Therapy with Anticancer Drugs (Deadline: 31 August 2023)
- Nanoparticles for RNA and DNA Delivery towards Personalized Medicine (Deadline: 31 August 2023)
- Editorial Board Members’ Collection Series: Progress and Challenges of Gene Delivery Systems (Deadline: 30 September 2023)
- Nanotechnology-Enabled Delivery and Detection of Nucleic Acids (Deadline: 30 September 2023)
- Advances in the Development of mRNA Medicines and mRNA Vaccines (Deadline: 30 September 2023)
- Recent Advances in Nanoparticles for Gene Delivery (Deadline: 30 September 2023)
- Bacteriophages, Critical Biocatalysts of Bacterial Doom: The Dawn of a New Era in the Fight against Multidrug Resistant Bacteria, 2nd Edition (Deadline: 10 October 2023)
- Peptide-Based and Hybrid Carriers for Nucleic Acids Delivery (Deadline: 20 November 2023)
- Mesenchymal Stem/Stromal Cell Extracellular Vesicles: From Active Principle to Next Generation Drug Delivery (Deadline: 20 November 2023)
